國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The science and business of drug dis...

SpringerLink (Online service)

The science and business of drug discoverydemystifying the jargon /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The science and business of drug discoveryby Edward D. Zanders.
其他題名:	demystifying the jargon /
作者:	Zanders, Edward D.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	xvii, 402 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Drug developmentCongresses.
電子資源:	https://doi.org/10.1007/978-3-030-57814-5
ISBN:	9783030578145$q(electronic bk.)

The science and business of drug discoverydemystifying the jargon /
Zanders, Edward D.

The science and business of drug discoverydemystifying the jargon /[electronic resource] :by Edward D. Zanders. - Second edition. - Cham :Springer International Publishing :2020. - xvii, 402 p. :ill., digital ;24 cm.

Introduction -- PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry -- Introduction to Drugs and Drug Targets -- Background to chemistry of small and large molecules -- Laying the foundations- Drug discovery from antiquity to the twenty first century -- Part II-The drug development pipeline - discovery to testing in humans -- Drug discovery pipeline overview -- Target discovery -- Medicinal chemistry -- Biotherapeutics -- Screening for hits -- Process chemistry and formulation -- Preclinical development -- Part III-The drug development pipeline - clinical trials to marketing authorisation -- Clinical trials -- Regulatory affairs and marketing approval -- Diagnostics and personalized medicine -- Putting it All Together: a drug development case history -- Part IV- The Global Pharmaceuticals Business -- Commercial aspects of drug development -- Challenges and responses -- Part V - Professional Interactions with the Drug Discovery Industry -- Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives -- Recruitment Executives -- Pharmaceutical translators and Interpreters.

The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the twenty chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices. The following topics are covered: Different types of drugs: from small molecules to stem cells Background to chemistry of small and large molecules Historical background to drug discovery, pharmacology and biotechnology The drug discovery pipeline: from target discovery to marketed medicine Commercial aspects of drug discovery Challenges to the biopharmaceutical industry and its responses Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators.

ISBN: 9783030578145$q(electronic bk.)

Standard No.: 10.1007/978-3-030-57814-5doiSubjects--Topical Terms:

451868
Drug development
--Congresses.

LC Class. No.: RM301.25 / .Z363 2020

Dewey Class. No.: 615.19

The science and business of drug discoverydemystifying the jargon /
LDR:03507nmm a2200337 a 4500 001 589262
003 DE-He213
005 20210217103152.0
006 m d
007 cr nn 008maaau
008 210601s2020 sz s 0 eng d
020 $a 9783030578145$q(electronic bk.)
020 $a 9783030578138$q(paper)
024 7 $a 10.1007/978-3-030-57814-5 $2 doi
035 $a 978-3-030-57814-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25 $b .Z363 2020
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .Z27 2020
100 1 $a Zanders, Edward D. $3 522357
245 1 4 $a The science and business of drug discovery $h [electronic resource] : $b demystifying the jargon / $c by Edward D. Zanders.
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a xvii, 402 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry -- Introduction to Drugs and Drug Targets -- Background to chemistry of small and large molecules -- Laying the foundations- Drug discovery from antiquity to the twenty first century -- Part II-The drug development pipeline - discovery to testing in humans -- Drug discovery pipeline overview -- Target discovery -- Medicinal chemistry -- Biotherapeutics -- Screening for hits -- Process chemistry and formulation -- Preclinical development -- Part III-The drug development pipeline - clinical trials to marketing authorisation -- Clinical trials -- Regulatory affairs and marketing approval -- Diagnostics and personalized medicine -- Putting it All Together: a drug development case history -- Part IV- The Global Pharmaceuticals Business -- Commercial aspects of drug development -- Challenges and responses -- Part V - Professional Interactions with the Drug Discovery Industry -- Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives -- Recruitment Executives -- Pharmaceutical translators and Interpreters.
520 $a The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the twenty chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices. The following topics are covered: Different types of drugs: from small molecules to stem cells Background to chemistry of small and large molecules Historical background to drug discovery, pharmacology and biotechnology The drug discovery pipeline: from target discovery to marketed medicine Commercial aspects of drug discovery Challenges to the biopharmaceutical industry and its responses Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators.
650 0 $a Drug development $v Congresses. $3 451868
650 0 $a Pharmaceutical industry $3 193699
650 0 $a Pharmacology. $3 218135
650 0 $a Pharmacy. $3 218145
650 0 $a Pharmaceutical technology. $3 237657
650 0 $a Chemistry, Physical and theoretical. $3 188610
650 0 $a Biotechnology. $3 188829
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Drug Safety and Pharmacovigilance. $3 701740
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Theoretical and Computational Chemistry. $3 273882
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-57814-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)